nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0131	0.0131	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0131	0.0131	CbGpPWpGaD
Tiotropium—CHRM5—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0125	0.0125	CbGpPWpGaD
Tiotropium—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.0119	0.0119	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.0114	0.0114	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0112	0.0112	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0105	0.0105	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00972	0.00972	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00969	0.00969	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0096	0.0096	CbGpPWpGaD
Tiotropium—CHRM5—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00958	0.00958	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00924	0.00924	CbGpPWpGaD
Tiotropium—CHRM3—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00897	0.00897	CbGpPWpGaD
Tiotropium—CHRM1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00879	0.00879	CbGpPWpGaD
Tiotropium—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00876	0.00876	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00827	0.00827	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00813	0.00813	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00786	0.00786	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00784	0.00784	CbGpPWpGaD
Tiotropium—CHRM5—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00776	0.00776	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0074	0.0074	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00738	0.00738	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00737	0.00737	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00731	0.00731	CbGpPWpGaD
Tiotropium—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00727	0.00727	CbGpPWpGaD
Tiotropium—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00716	0.00716	CbGpPWpGaD
Tiotropium—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00682	0.00682	CbGpPWpGaD
Tiotropium—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00675	0.00675	CbGpPWpGaD
Tiotropium—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00672	0.00672	CbGpPWpGaD
Tiotropium—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00666	0.00666	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00642	0.00642	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0063	0.0063	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00603	0.00603	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00594	0.00594	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00582	0.00582	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0058	0.0058	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00575	0.00575	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00572	0.00572	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.0057	0.0057	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00565	0.00565	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00561	0.00561	CbGpPWpGaD
Tiotropium—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00547	0.00547	CbGpPWpGaD
Tiotropium—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00545	0.00545	CbGpPWpGaD
Tiotropium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Tiotropium—SLC22A4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00538	0.00538	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00519	0.00519	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00517	0.00517	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00516	0.00516	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00512	0.00512	CbGpPWpGaD
Tiotropium—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00454	0.00454	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00443	0.00443	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00442	0.00442	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00438	0.00438	CbGpPWpGaD
Tiotropium—SLC22A4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00436	0.00436	CbGpPWpGaD
Tiotropium—SLC22A4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00427	0.00427	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00418	0.00418	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00417	0.00417	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00413	0.00413	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00404	0.00404	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00395	0.00395	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00394	0.00394	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.0039	0.0039	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0038	0.0038	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00379	0.00379	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00375	0.00375	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00375	0.00375	CbGpPWpGaD
Tiotropium—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00368	0.00368	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00364	0.00364	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00362	0.00362	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00359	0.00359	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00356	0.00356	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00327	0.00327	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00327	0.00327	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00323	0.00323	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00319	0.00319	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Tiotropium—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00297	0.00297	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00296	0.00296	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00296	0.00296	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00292	0.00292	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00289	0.00289	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00288	0.00288	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00279	0.00279	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00252	0.00252	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00251	0.00251	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.0025	0.0025	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0025	0.0025	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00247	0.00247	CbGpPWpGaD
Tiotropium—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00241	0.00241	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.0023	0.0023	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00229	0.00229	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00228	0.00228	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00227	0.00227	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00227	0.00227	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00225	0.00225	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00224	0.00224	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00224	0.00224	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00223	0.00223	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00223	0.00223	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00222	0.00222	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00209	0.00209	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00206	0.00206	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00205	0.00205	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00201	0.00201	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.002	0.002	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00144	0.00144	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00134	0.00134	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00134	0.00134	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00134	0.00134	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00133	0.00133	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00124	0.00124	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000999	0.000999	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.00099	0.00099	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000965	0.000965	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000875	0.000875	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000872	0.000872	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000864	0.000864	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00086	0.00086	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000857	0.000857	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000849	0.000849	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.00084	0.00084	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000831	0.000831	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000831	0.000831	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000815	0.000815	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000794	0.000794	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000792	0.000792	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000784	0.000784	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000737	0.000737	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000737	0.000737	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000729	0.000729	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000727	0.000727	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000723	0.000723	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.00072	0.00072	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000703	0.000703	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000701	0.000701	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000697	0.000697	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000695	0.000695	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000694	0.000694	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000688	0.000688	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00068	0.00068	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000678	0.000678	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000671	0.000671	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000667	0.000667	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000658	0.000658	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000638	0.000638	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000613	0.000613	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000585	0.000585	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000583	0.000583	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000578	0.000578	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000559	0.000559	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000549	0.000549	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000509	0.000509	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000507	0.000507	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000503	0.000503	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000497	0.000497	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000488	0.000488	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000476	0.000476	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000469	0.000469	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000468	0.000468	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000463	0.000463	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000463	0.000463	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000462	0.000462	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000457	0.000457	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000449	0.000449	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000448	0.000448	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000446	0.000446	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000443	0.000443	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000401	0.000401	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000377	0.000377	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000335	0.000335	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000335	0.000335	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000334	0.000334	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000331	0.000331	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000325	0.000325	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000319	0.000319	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000316	0.000316	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000267	0.000267	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000265	0.000265	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000264	0.000264	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000262	0.000262	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000223	0.000223	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000222	0.000222	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.00022	0.00022	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000219	0.000219	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000174	0.000174	CbGpPWpGaD
